Pryor Medical Devices has received U.S. Food and Drug Administration (FDA) approval for the sale and distribution of its ER-REBOA catheter.
REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) is a minimally invasive technique used by the trauma, critical care and emergency medicine community to temporarily occlude large vessels using a balloon.
"We are proud to be the first to market with a balloon occlusion catheter designed specifically for this community. They asked for the unique combination of features found on the ER-REBOA catheter, and we look forward to getting it to them," said David A. Spencer, CEO of Pryor Medical Devices.
The medical device company has scheduled first delivery of its catheters for January 1, 2016.